Law firm Kaplan Fox & Kilsheimer LLP has launched an investigation into possible securities violations involving Alignment Healthcare, Inc. (NASDAQ:ALHC) following a whistleblower complaint filed on July 8, 2026. The complaint, submitted by a former company executive, alleges that Alignment Healthcare engaged in accounting irregularities that artificially boosted previously reported financial results. In response to the news, ALHC shares dropped $4.02, or 16.7%, closing at $20.03 per share on July 8, 2026. Investors impacted by the decline are closely monitoring the investigation for updates.

Key Points

• Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities violations
• Whistleblower complaint by a former executive alleges systematic misclassification of operating expenses as capital expenditures, inflating Adjusted EBITDA
• ALHC stock fell $4.02 per share (16.7%) on July 8, 2026, closing at $20.03
• Investors who incurred losses are encouraged to contact the law firm to understand their legal options

Whistleblower Alleges Inflated Adjusted EBITDA at Alignment Healthcare

The whistleblower complaint, filed by a former executive of Alignment Healthcare, accuses the company of "accounting irregularities" that "artificially inflated" its previously reported and forecasted financial results. The allegations focus on Adjusted EBITDA, a critical non-GAAP financial metric pivotal to Alignment Healthcare’s reported...

Read Full Story: https://news.google.com/rss/articles/CBMi1wFBVV95cUxPM2RqRC1aTERkVmhTWGNzRkwz...